Detection of plasmid-mediated AmpC in Escherichia coli , Klebsiella pneumoniae and Proteus mirabilis : Table 1
Authors:
- 5 December 2007
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 61 (5) , 642-644
Abstract
Aims: This study investigated the prevalence of plasmid-mediated AmpC production in selected clinical isolates of Escherichia coli , Klebsiella species and Proteus mirabilis , and compared the results of boronic acid disc screening with conventional susceptibility testing for the detection of AmpC-positive isolates. Methods: E coli , Klebsiella species and P mirabilis with reduced susceptibility to amoxycillin-clavulanate, cefuroxime and cephalexin, but without phenotypic evidence of extended-spectrum β-lactamases were screened for AmpC activity using enzyme-extraction methods. The presence of plasmid-mediated ampC was determined by multiplex PCR. Antibiotic susceptibilities were determined using both disc and dilution-based methods. A disc-based screening method for detection of AmpC-producing strains was evaluated using boronic acid as an inhibitor of AmpC, and cefoxitin as the antibiotic substrate. Results: Plasmid-mediated ampC was present in 26% of study isolates, with CMY-like enzymes detected predominantly in E coli and DHA-like enzymes predominantly in Klebsiella pneumoniae . Current susceptibility methods failed to detect a significant proportion of plasmid-mediated AmpC-producing isolates, with 33% of such strains interpreted as susceptible to third-generation cephalosporins using current Clinical Laboratory Standards Institute breakpoints. The boronic acid disc method showed sensitivity and specificity of 90% and 98% respectively in detecting AmpC-positive isolates. Conclusion: The prevalence of plasmid-mediated ampC was high in the study population, and may be missed by conventional susceptibility testing methods. Inhibitor-based screening methods would improve detection of this emerging resistance phenotype.Keywords
This publication has 9 references indexed in Scilit:
- Population-based Laboratory Surveillance for AmpC β-Lactamase–producing Escherichia coli, CalgaryEmerging Infectious Diseases, 2007
- Wide geographic spread of diverse acquired AmpC -lactamases among Escherichia coli and Klebsiella spp. in the UK and IrelandJournal of Antimicrobial Chemotherapy, 2006
- Inhibitor-Based Methods for Detection of Plasmid-Mediated AmpC β-Lactamases in Klebsiella spp., Escherichia coli , and Proteus mirabilisJournal of Clinical Microbiology, 2005
- Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-β-Lactamase-Producing Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2004
- New Method for Laboratory Detection of AmpC β-Lactamases in Escherichia coli and Klebsiella pneumoniaeJournal of Clinical Microbiology, 2004
- Occurrence of Extended-Spectrum and AmpC Beta-Lactamases in Bloodstream Isolates of Klebsiella pneumoniae: Isolates Harbor Plasmid-Mediated FOX-5 and ACT-1 AmpC Beta-LactamasesJournal of Clinical Microbiology, 2003
- Detection of Plasmid-Mediated AmpC β-Lactamase Genes in Clinical Isolates by Using Multiplex PCRJournal of Clinical Microbiology, 2002
- Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniaeJournal of Antimicrobial Chemotherapy, 2000
- Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility PatternsClinical Infectious Diseases, 1988